1-20 of 23
Authors: Alba A. Brandes
Save search
Sort by
Journal Article

CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY Free

PDF
Brigitta G Baumert and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii97–viii98, https://doi.org/10.1093/neuonc/noae165.0381
Published: 11 November 2024
Journal Article

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial Open Access

PDF
Antonio Omuro and others
Neuro-Oncology, Volume 25, Issue 1, January 2023, Pages 123–134, https://doi.org/10.1093/neuonc/noac099
Published: 14 April 2022
Journal Article

Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period Open Access

PDF
Marijke B Coomans and others
Neuro-Oncology, Volume 24, Issue 12, December 2022, Pages 2159–2169, https://doi.org/10.1093/neuonc/noac097
Published: 11 April 2022
Journal Article

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma Open Access

PDF
C Mircea S Tesileanu and others
Neuro-Oncology, Volume 23, Issue 9, September 2021, Pages 1547–1559, https://doi.org/10.1093/neuonc/noab088
Published: 29 April 2021
Journal Article

IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP Open Access

PDF
Craig Erker and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii355, https://doi.org/10.1093/neuonc/noaa222.340
Published: 04 December 2020
Journal Article

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status? Open Access

PDF
Marijke B Coomans and others
Neuro-Oncology, Volume 21, Issue 11, November 2019, Pages 1447–1457, https://doi.org/10.1093/neuonc/noz118
Published: 05 June 2019
Journal Article

LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410 Free

PDF
Martin van den Bent and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi316, https://doi.org/10.1093/neuonc/nox213
Published: 17 November 2017
Journal Article

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma Free

PDF
Mark W Kieran and others
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1542–1552, https://doi.org/10.1093/neuonc/nox109
Published: 09 June 2017
Journal Article

Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee Free

PDF
Katherine E Warren and others
Neuro-Oncology, Volume 20, Issue 1, January 2018, Pages 13–23, https://doi.org/10.1093/neuonc/nox087
Published: 25 April 2017
Journal Article
EDITOR'S CHOICE

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria Free

PDF
Lakshmi Nayak and others
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 625–635, https://doi.org/10.1093/neuonc/nox029
Published: 18 April 2017
Journal Article

ACTR-19. BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA: RETROSPECTIVE ANALYSIS OF AVAglio Free

PDF
Olivier Chinot and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi5, https://doi.org/10.1093/neuonc/now212.018
Published: 07 November 2016
Journal Article

PDCT-13. GUIDELINES FOR RESPONSE ASSESSMENT IN MEDULLOBLASTOMA AND OTHER LEPTOMENINGEAL SEEDING TUMORS: A REPORT FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP Free

PDF
Katherine Warren and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi148–vi149, https://doi.org/10.1093/neuonc/now212.617
Published: 07 November 2016
Journal Article

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma Free

PDF
Alba A. Brandes and others
Neuro-Oncology, Volume 18, Issue 9, September 2016, Pages 1304–1312, https://doi.org/10.1093/neuonc/now035
Published: 06 March 2016
Journal Article

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma Free

PDF
Alba A. Brandes and others
Neuro-Oncology, Volume 18, Issue 8, August 2016, Pages 1146–1156, https://doi.org/10.1093/neuonc/now009
Published: 21 February 2016
Journal Article

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM]) Get access

PDF
Tim Cloughesy and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v12, https://doi.org/10.1093/neuonc/nou237.18
Published: 01 November 2014
Journal Article

ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA Get access

PDF
Tim Cloughesy and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v81, https://doi.org/10.1093/neuonc/nou255.12
Published: 01 November 2014
Journal Article

NI-26COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE. Get access

PDF
Enrico Franceschi and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Pages v143–v144, https://doi.org/10.1093/neuonc/nou264.25
Published: 01 November 2014
Journal Article

AT-11FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM Get access

PDF
Alba A. Brandes and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v10, https://doi.org/10.1093/neuonc/nou237.11
Published: 01 November 2014
Journal Article

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma Get access

PDF
Enrico Franceschi and others
Neuro-Oncology, Volume 14, Issue 12, December 2012, Pages 1503–1510, https://doi.org/10.1093/neuonc/nos256
Published: 22 October 2012
Journal Article

O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications Get access

PDF
Alba A. Brandes and others
Neuro-Oncology, Volume 12, Issue 3, March 2010, Pages 283–288, https://doi.org/10.1093/neuonc/nop050
Published: 01 February 2010